14.56
+0.02
+(0.14%)
At close: January 31 at 4:25:00 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in NOK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 1 |
| Avg. Estimate | -0 | 0 | 0.08 | 0.23 |
| Low Estimate | -0.02 | 0 | 0.07 | 0.23 |
| High Estimate | 0.01 | 0 | 0.09 | 0.23 |
| Year Ago EPS | 0.04 | 0.06 | 0.37 | 0.08 |
Revenue Estimate
| Currency in NOK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | 25.75M | -- | 106.5M | 122.6M |
| Low Estimate | 25.4M | -- | 105.25M | 122.06M |
| High Estimate | 26.11M | -- | 107.75M | 123.14M |
| Year Ago Sales | 28.38M | -- | 118.94M | 106.5M |
| Sales Growth (year/est) | -9.26% | -- | -10.46% | 15.11% |
Earnings History
| Currency in NOK | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.11 | 0.07 | 0.04 | 0.07 |
| EPS Actual | 0.04 | 0.06 | 0.07 | -0.03 |
| Difference | -0.07 | -0.01 | 0.03 | -0.1 |
| Surprise % | -63.62% | -16.85% | 56.35% | -141.10% |
EPS Trend
| Currency in NOK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0 | 0 | 0.08 | 0.23 |
| 7 Days Ago | -0.02 | 0 | 0.08 | 0.27 |
| 30 Days Ago | -0.02 | 0 | 0.08 | 0.27 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0.14 | 0 | 0.35 | 0.67 |
EPS Revisions
| Currency in NOK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | -- | 1 | 1 |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AZT.OL | -108.50% | -- | -78.31% | 188.79% |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
CLBIO.ST Corline Biomedical AB
9.42
+1.73%
PCIB.OL PCI Biotech Holding ASA
1.2500
+2.12%
DIABIO.ST Diagonal Bio AB (publ)
0.0189
-5.50%
NYKD.OL Nykode Therapeutics AS
2.6820
+1.98%
OTLC Oncotelic Therapeutics, Inc.
0.0303
+8.21%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
CAMX.ST Camurus AB (publ)
596.00
-0.17%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
30.60
+2.00%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
APRE Aprea Therapeutics, Inc.
3.9100
+0.51%